Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
5.25
+0.44 (9.15%)
At close: Oct 29, 2025, 4:00 PM EDT
5.25
0.00 (0.00%)
After-hours: Oct 29, 2025, 4:00 PM EDT
Ekso Bionics Holdings Revenue
Ekso Bionics Holdings had revenue of $4.23M in the quarter ending September 30, 2025, with 2.37% growth. This brings the company's revenue in the last twelve months to $14.75M, down -16.59% year-over-year. In the year 2024, Ekso Bionics Holdings had annual revenue of $17.93M, down -1.94%.
Revenue (ttm)
$14.75M
Revenue Growth
-16.59%
P/S Ratio
0.66
Revenue / Employee
$223,470
Employees
66
Market Cap
13.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.93M | -354.00K | -1.94% |
| Dec 31, 2023 | 18.28M | 5.37M | 41.57% |
| Dec 31, 2022 | 12.91M | 1.67M | 14.81% |
| Dec 31, 2021 | 11.25M | 2.36M | 26.62% |
| Dec 31, 2020 | 8.88M | -5.04M | -36.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
EKSO News
- 8 hours ago - Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 1 day ago - Ekso Bionics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Ekso Bionics Holdings, Inc. (EKSO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Ekso Bionics Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to Follow - GlobeNewsWire
- 3 months ago - Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country - GlobeNewsWire
- 4 months ago - Ekso Bionics' Acceptance into NVIDIA Connect Program Bears Early Fruit - GlobeNewsWire
- 5 months ago - Ekso Bionics Announces New Effective Date of Reverse Stock Split - GlobeNewsWire